Merck's Keytruda, ready to challenge Bristol-Myers Squibb, posts kidney cancer...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 18, 2018 at 1:12 PM.

  1. #1 cafead, Oct 18, 2018 at 1:12 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Merck’s Keytruda knows how to make an entrance. On Thursday, it hit the scene with kidney cancer combination data that could snag it a new indication months earlier than anticipated.

    article source
     
    Quote

Reply to Thread